AR109380A1 - METHODS TO TREAT EOSINOPHYL ESOPHAGITIS - Google Patents

METHODS TO TREAT EOSINOPHYL ESOPHAGITIS

Info

Publication number
AR109380A1
AR109380A1 ARP170102312A ARP170102312A AR109380A1 AR 109380 A1 AR109380 A1 AR 109380A1 AR P170102312 A ARP170102312 A AR P170102312A AR P170102312 A ARP170102312 A AR P170102312A AR 109380 A1 AR109380 A1 AR 109380A1
Authority
AR
Argentina
Prior art keywords
methods
esophagitis
treat
eosinophyl
administering
Prior art date
Application number
ARP170102312A
Other languages
Spanish (es)
Inventor
Gail Comer
Brian Meltzer
Original Assignee
Adare Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adare Pharmaceuticals Inc filed Critical Adare Pharmaceuticals Inc
Publication of AR109380A1 publication Critical patent/AR109380A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Métodos para tratar la inflamación del tracto gastrointestinal superior, en especial el esófago, administrando un corticosteroide oral. En algunos casos, los métodos incluyen tratar esofagitis eosinofílica (EoE) administrando un corticosteroide oral en una fase de inducción y una fase de mantenimiento. Los métodos incluyen tratar la EoE administrando el corticosteroide oral a la noche y/o cuando el paciente se encuentra recostado.Methods to treat inflammation of the upper gastrointestinal tract, especially the esophagus, by administering an oral corticosteroid. In some cases, the methods include treating eosinophilic esophagitis (EoE) by administering an oral corticosteroid in an induction phase and a maintenance phase. The methods include treating EoE by administering the oral corticosteroid at night and / or when the patient is lying down.

ARP170102312A 2016-08-18 2017-08-18 METHODS TO TREAT EOSINOPHYL ESOPHAGITIS AR109380A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662376703P 2016-08-18 2016-08-18

Publications (1)

Publication Number Publication Date
AR109380A1 true AR109380A1 (en) 2018-11-28

Family

ID=64499935

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170102312A AR109380A1 (en) 2016-08-18 2017-08-18 METHODS TO TREAT EOSINOPHYL ESOPHAGITIS

Country Status (1)

Country Link
AR (1) AR109380A1 (en)

Similar Documents

Publication Publication Date Title
UY37370A (en) METHODS TO TREAT EOSINOPHYL ESOPHAGITIS
MX2019006864A (en) Treatment of a disease of the gastrointestinal tract with a tnf inhibitor.
MX2019006821A (en) Treatment of a disease of the gastrointestinal tract with a jak inhibitor and devices.
MX2019006823A (en) Treatment of a disease of the gastrointestinal tract with an il-12/il-23 inhibitor released using an ingestible device.
PE20190338A1 (en) METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL
WO2014197632A3 (en) Methods, systems and devices for reducing the luminal surface area of the gastrointestinal tract
BR112017018964A2 (en) use of plinabulin and methods to treat brain tumor
CO2018004776A2 (en) Therapeutic compositions for the treatment of human immunodeficiency virus
EA201692436A1 (en) MEDICAL APPLICATION
CL2017000050A1 (en) Combination Therapy for Cancer
PH12017502375A1 (en) Method of treating inflammation using natural compounds and/or diet
MX2016009231A (en) Administration of tasimelteon under fasted conditions.
WO2016029136A8 (en) 3-amidobenzamides and uses thereof for increasing cellular levels of a3g
DOP2023000155A (en) TREATMENT AND MAINTENANCE THERAPY FOR BLADDER CANCER WITH GEMCITABINE
BR112016029437A2 (en) methods for treatment and prevention of vascular instability diseases
AR102308A1 (en) PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OR PREVENTION OF VITAMIN AND MINERAL DEFICIENCIES IN PATIENTS SUBJECTED TO GASTRIC BYPASS SURGERY
AR109380A1 (en) METHODS TO TREAT EOSINOPHYL ESOPHAGITIS
EA201891008A3 (en) TREATMENT OF SYMPTOMS ASSOCIATED WITH ANDROGEN-DEPRIVATION THERAPY
RU2014154366A (en) APPLICATION OF THE PROBIOTIC STRAIN OF THE MICROOORGANISM ENTEROCOCCUS FAECIUM L3 FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
EA201790089A1 (en) PHARMACEUTICAL MEANS FOR THE TREATMENT OF THE HEAD OF VARIOUS ETIOLOGY
UA99349U (en) A drug for local treatment of inflammatory diseases of different etiologies
UA116397C2 (en) METHOD OF SURGICAL TREATMENT OF DAMONAL INJURY
UA115377U (en) METHOD OF TREATMENT OF PATIENTS WITH SOMATO-FORMAL VEGETABLE DYSFUNCTION COMBINED WITH CHRONIC NON-STONE CHOLECYSTITIS
EA201692163A1 (en) MEDICINE FOR THE TREATMENT OF PATIENTS WITH TINNITUS
UA111998U (en) THE USE OF DECAMETOXIN AS A PHARMACEUTICAL ACTIVE SUBSTANCE FOR TREATMENT OF DISEASES OF THE Gastrointestinal AND INTESTINAL INFECTIONS

Legal Events

Date Code Title Description
FB Suspension of granting procedure